Clinical Trial Update: Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome. [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of dapagliflozin in non-diabetic patients with nephrotic syndrome is ongoing; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Ain Shams University | Conditions: Nephrotic Syndrome | Phase 4 | Status: UNKNOWN